Literature DB >> 12174907

Tumor marker potential of serum matrix metalloproteinases in patients with head and neck cancer.

C Kuropkat1, S Plehn, U Herz, A A Dünne, H Renz, J A Werner.   

Abstract

BACKGROUND: Elevated expression of matrix metalloproteinases (MMPs) is suggested to have tumor marker potential in various tumors. MMPs are capable of disintegrating the basement membrane, which is a main characteristic of tumor invasion. They are specifically inactivated by tissue inhibitors of metalloproteinases (TIMPs). Squamous cell carcinomas of the head and neck (SCCHN) are known to be highly invasive tumors with early locoregional metastatic spread. PATIENTS AND METHODS: To investigate the tumor marker potential of MMPs in SCCHN, MMP-2, -3, -8, -9, -13 and TIMP-1 serum levels were determined in 73 patients and compared to 74 controls. A correlation with T- and N-status, UICC-staging and grading was performed. Additionally, the influence of inflammation on the MMP serum concentration was examined.
RESULTS: Significant differences between patients with SCCHN and controls were seen for MMP-3, -8 and -9. A significant correlation was found between MMP-8 concentration and T-status, N-status and UICC-staging. No correlation with the grading of the tumor was observed. Inflammatory diseases did not affect MMP and TIMP levels significantly.
CONCLUSION: Some MMPs are elevated in the serum of patients with SCCHN and especially MMP-8 showed interesting tumor marker potential.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12174907

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  12 in total

1.  Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer.

Authors:  Ragini D Singh; N Haridas; Jayendra B Patel; Franky D Shah; Shilin N Shukla; Pankaj M Shah; Prabhudas S Patel
Journal:  Indian J Clin Biochem       Date:  2010-08-25

Review 2.  Updated overview of current biomarkers in head and neck carcinoma.

Authors:  Kiran Dahiya; Rakesh Dhankhar
Journal:  World J Methodol       Date:  2016-03-26

Review 3.  Update of prognostic and predictive biomarkers in oropharyngeal squamous cell carcinoma: a review.

Authors:  Carolin M Grimminger; Peter V Danenberg
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-09-09       Impact factor: 2.503

4.  Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes.

Authors:  Amy Anne D Lassig; Anne M Joseph; Bruce R Lindgren; Bevan Yueh
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2017-07-01       Impact factor: 6.223

5.  Matrix metalloproteinase-8 promoter gene polymorphisms in Mexican women with ovarian cancer.

Authors:  Fabian Arechavaleta-Velasco; Rocio Cuevas-Antonio; Pablo Dominguez-Lopez; Isaias Estrada-Moscoso; Fazlollah Shahram Imani-Razavi; Moises Zeferino-Toquero; Laura Diaz-Cueto
Journal:  Med Oncol       Date:  2014-07-18       Impact factor: 3.064

6.  Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma.

Authors:  Hubert Vermeersch; Kris Mervillie; Christophe Lahorte; David Loose; Rudi Andre Dierck; Neil Steinmetz; Claude Cuvelier; Guido Slegers; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-11       Impact factor: 9.236

7.  Soluble interleukin-2 receptor and metalloproteinase-9 expression in head and neck cancer: prognostic value and analysis of their relationships.

Authors:  N El Houda Agueznay; C Badoual; S Hans; A Gey; B Vingert; S Peyrard; F Quintin-Colonna; P Ravel; P Bruneval; S Roncelin; B Lelongt; J Bertoglio; W H Fridman; D Brasnu; E Tartour
Journal:  Clin Exp Immunol       Date:  2007-08-03       Impact factor: 4.330

8.  Establishment of field change by expression of cytokeratins 8/18, 19, and MMP-9 in an apparently normal oral mucosa adjacent to squamous cell carcinoma: A immunohistochemical study.

Authors:  Alka D Kale; Deepa R Mane; Deepa Babji; Kushboo Gupta
Journal:  J Oral Maxillofac Pathol       Date:  2012-01

9.  High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.

Authors:  Chung-Han Hsin; Mu-Kuan Chen; Chih-Hsin Tang; Huang-Pin Lin; Ming-Yung Chou; Chiao-Wen Lin; Shun-Fa Yang
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

10.  A list of candidate cancer biomarkers for targeted proteomics.

Authors:  Malu Polanski; N Leigh Anderson
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.